Meeting or exceeding all internationally recognized laboratory and manufacturing quality standards in our industry is a core principle at Dalton
Toronto, Ontario (PRWEB) May 30, 2012
Dalton Pharma Services, a privately owned Canadian pharmaceutical services provider to leading pharmaceutical companies, today announced that the company has received GLP certification from The Standards Council of Canada.
SCC accreditation is recognized around the globe. In Canada, SCC administers the OECD GLP initiative. OECD (Organization for Economic Development and Co-operation) has 34 member countries, including Canada, Germany, Japan, and the US.
Ildiko Riss, Director of Quality at Dalton, noted “The auditing procedure of SCC was very rigorous. The GLP certificate issued as a result of the inspection and audits covers the Field of Pharmaceuticals and the following areas: Analytical and Clinical Chemistry Testing; Pharmacokinetic testing; and Physical-chemical testing. Dalton’s certificate can be viewed on the SCC website (http://www.scc.ca).”
“Meeting or exceeding all internationally recognized laboratory and manufacturing quality standards in our industry is a core principle at Dalton”, said Peter Pekos, President and CEO. “The confirmation of Dalton’s GLP compliance is evidence of this commitment to quality. I am very proud of the dedication and accomplishments of our Quality Group.”
“This year, Dalton is celebrating 25 years in business supplying innovative solutions to the pharmaceutical industry. Regulatory compliance has been a key factor in our success, and emphasis on compliance will continue as we develop the medicines of the future,” added Pekos.
Dalton Chemical Laboratories Inc. o/a Dalton Pharma Services is a Health Canada approved contract pharmaceutical manufacturer that supplies chemistry, analytical and formulation development services to the biotechnology and pharmaceutical industries in the areas of chemistry, medicinal chemistry and fine chemical manufacture. Dalton provides cGMP manufacturing of solid dosage forms and aseptic filling services to its customers at any stage of the regulatory process (Phase I, II, III or commercial). In its state of the art cGMP facilities, Dalton produces active pharmaceutical ingredients at the gram or kilogram scale. Dalton conducts aseptic fills to produce batches of finished drug product in vials or syringes, either aseptically filled or terminally sterilized, under fully validated conditions. In addition, Dalton’s analytical chemistry laboratory offers method development, validation and ICH stability programs to its clients. Further information can be found at http://www.dalton.com.